Dr. Robbins was the recipient of numerous awards during his long career (he was still actively working in his 70s), including the prestigious Lasker Award Winner in 1996 for the vaccine for preventing meningitis in children. Together with his colleague, Dr. Rachel Schneerson, they developed the polysaccharide-protein conjugate vaccine for Hemophilus influenzae type b (Hib), which can cause meningitis in children. The Lasker Award is bestowed annually to those who have made major contributions to medical science.
Dive
class
grid-col-6
Span
class
caption
Dr. Schneerson (left) and Dr. Robbins (right)
Span
class
credit
FDA History Office
Dive
preface
class
grid-row grid-gap
Dive
class
grid-col-8
Dr. Robbins was also the Sabin Gold Medal winner in 2001 for hispivotal role in the development of Hib conjugate vaccine, which is now used throughout the world. The use of this vaccine led to a dramatic decline in the number of infants and children suffering from meningitis and other systematic infections such as osteomyelitis and pneumonia. He received theWorld Health Organization Children’s Vaccine Initiative Pasteur Award (with Dr. Rachel Schneerson) in 2006, and Thailand’s Prince Mahidol Foundation Award for Public Health in 2017 (with Drs. Anderson and Schneerson).
Info
Dr. Robbins worked in Building 29, Rooms 120 and 122.
Dive
class
grid-col-4
Span
class
caption
Dr. John B. Robbins holding the Albert Lasker Clinical Medical Research Award.
